$7.78 Billion is the total value of C WorldWide Group Holding A/S's 172 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 15.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HD | Buy | HOME DEPOT INC | $632,114,000 | +6.5% | 3,051,476 | +0.3% | 8.12% | -1.4% |
| AMZN | Buy | AMAZON INC | $610,406,000 | +18.2% | 304,746 | +0.3% | 7.84% | +9.4% |
| GOOG | Buy | ALPHABET INCcap stk cl c | $579,633,000 | +7.3% | 485,671 | +0.3% | 7.44% | -0.7% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $547,106,000 | +18.1% | 2,241,502 | +0.2% | 7.03% | +9.3% |
| ECL | Buy | ECOLAB INC | $534,770,000 | +12.1% | 3,410,955 | +0.3% | 6.87% | +3.8% |
| FB | Buy | FACEBOOK INCcl a | $414,707,000 | -15.2% | 2,521,629 | +0.2% | 5.33% | -21.5% |
| KO | Buy | COCA COLA CO | $375,379,000 | +12.2% | 8,126,845 | +6.5% | 4.82% | +3.8% |
| XOM | New | EXXON MOBIL CORP | $363,290,000 | – | 4,273,004 | +100.0% | 4.67% | – |
| FRC | Buy | FIRST REP BK SAN FRANCISCO C | $306,412,000 | -0.8% | 3,191,797 | +0.0% | 3.94% | -8.2% |
| PG | Buy | PROCTER AND GAMBLE CO | $271,853,000 | +140.0% | 3,266,283 | +125.1% | 3.49% | +122.3% |
| HDB | Buy | HDFC BANK LTD | $165,994,000 | -5.2% | 1,764,009 | +5.8% | 2.13% | -12.3% |
| PFE | Buy | PFIZER INC | $29,073,000 | +53.9% | 659,711 | +26.7% | 0.37% | +42.4% |
| BIIB | Buy | BIOGEN INC | $20,870,000 | +48.0% | 59,070 | +21.6% | 0.27% | +36.7% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $14,522,000 | +32.4% | 75,343 | +16.8% | 0.19% | +23.0% |
| HCA | Buy | HCA HEALTHCARE INC | $12,900,000 | +58.1% | 92,727 | +16.6% | 0.17% | +46.9% |
| CELG | Buy | CELGENE CORP | $11,347,000 | +16.1% | 126,797 | +3.0% | 0.15% | +7.4% |
| AMRN | New | AMARIN CORP PLCspons adr new | $11,064,000 | – | 680,000 | +100.0% | 0.14% | – |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $8,396,000 | -1.7% | 49,935 | +0.7% | 0.11% | -9.2% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $7,315,000 | +37.4% | 75,431 | +33.5% | 0.09% | +27.0% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $5,957,000 | +6.9% | 223,682 | +51.6% | 0.08% | 0.0% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $5,888,000 | +32.5% | 34,088 | +7.0% | 0.08% | +22.6% |
| HOLX | Buy | HOLOGIC INC | $5,435,000 | +53.8% | 132,631 | +49.2% | 0.07% | +42.9% |
| NKTR | New | NEKTAR THERAPEUTICS | $4,936,000 | – | 80,975 | +100.0% | 0.06% | – |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $4,713,000 | +33.3% | 319,750 | +115.7% | 0.06% | +24.5% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $4,507,000 | -8.7% | 400,603 | +3.9% | 0.06% | -14.7% |
| ITCI | Buy | INTRA CELLULAR THERAPIES INC | $4,312,000 | +40.5% | 198,703 | +14.4% | 0.06% | +27.9% |
| PODD | Buy | INSULET CORP | $3,731,000 | +47.6% | 35,215 | +19.4% | 0.05% | +37.1% |
| FOMX | New | FOAMIX PHARMACEUTICALS LTD | $3,438,000 | – | 600,000 | +100.0% | 0.04% | – |
| TSRO | Buy | TESARO INC | $3,366,000 | -11.9% | 86,277 | +0.5% | 0.04% | -18.9% |
| INCY | Buy | INCYTE CORP | $3,248,000 | +5.8% | 47,023 | +2.6% | 0.04% | -2.3% |
| ONCE | Buy | SPARK THERAPEUTICS INC | $3,000,000 | -29.7% | 54,999 | +6.6% | 0.04% | -33.9% |
| SCI | Buy | SERVICE CORP INTL | $1,848,000 | +72.4% | 41,816 | +39.5% | 0.02% | +60.0% |
| T | Buy | AT&T INC | $1,858,000 | +192.1% | 55,342 | +179.5% | 0.02% | +166.7% |
| AY | Buy | ATLANTICA YIELD PLC | $1,774,000 | +6.0% | 86,234 | +4.0% | 0.02% | 0.0% |
| ARMK | Buy | ARAMARK | $1,746,000 | +45.3% | 40,580 | +25.2% | 0.02% | +29.4% |
| MCD | New | MCDONALDS CORP | $1,254,000 | – | 7,495 | +100.0% | 0.02% | – |
| KHC | New | KRAFT HEINZ CO | $1,189,000 | – | 21,583 | +100.0% | 0.02% | – |
| FNV | New | FRANCO NEVADA CORP | $923,000 | – | 14,759 | +100.0% | 0.01% | – |
| AVY | Buy | AVERY DENNISON CORP | $704,000 | +245.1% | 6,500 | +225.0% | 0.01% | +200.0% |
| BLUE | Buy | BLUEBIRD BIO INC | $357,000 | +8.5% | 2,442 | +16.4% | 0.01% | 0.0% |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $311,000 | +17.4% | 18,249 | +16.9% | 0.00% | 0.0% |
| XLRN | Buy | ACCELERON PHARMA INC | $302,000 | +37.3% | 5,278 | +16.3% | 0.00% | +33.3% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $279,000 | +6.9% | 3,622 | +16.8% | 0.00% | 0.0% |
| ESPR | Buy | ESPERION THERAPEUTICS INC NE | $222,000 | +31.4% | 4,999 | +16.1% | 0.00% | +50.0% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $271,000 | +44.9% | 5,248 | +17.1% | 0.00% | 0.0% |
| EXEL | Buy | EXELIXIS INC | $244,000 | -3.9% | 13,791 | +16.7% | 0.00% | -25.0% |
| RDUS | Buy | RADIUS HEALTH INC | $131,000 | -29.2% | 7,336 | +16.8% | 0.00% | -33.3% |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS IN | $183,000 | +76.0% | 1,446 | +16.2% | 0.00% | +100.0% |
| LXRX | Buy | LEXICON PHARMACEUTICALS INC | $171,000 | +3.0% | 16,037 | +16.1% | 0.00% | 0.0% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $169,000 | +57.9% | 8,147 | +15.9% | 0.00% | +100.0% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $107,000 | +37.2% | 13,227 | +18.6% | 0.00% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VISA INC | 37 | Q3 2023 | 15.5% |
| THERMO FISHER SCIENTIFIC INC | 37 | Q3 2023 | 11.2% |
| HDFC BANK LTD | 37 | Q3 2023 | 3.7% |
| ICICI BK LTD | 37 | Q3 2023 | 2.1% |
| CENTENE CORP DEL | 37 | Q3 2023 | 0.4% |
| DEX INC | 37 | Q3 2023 | 0.5% |
| BIOMARIN PHARMACEUTICAL INC | 37 | Q3 2023 | 0.3% |
| VERTEX PHARMACEUTICALS INC | 37 | Q3 2023 | 0.4% |
| INSULET CORP | 37 | Q3 2023 | 0.3% |
| CARA THERAPEUTICS INC | 37 | Q3 2023 | 0.2% |
View C WorldWide Group Holding A/S's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-03 |
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-03 |
| 13F-HR | 2023-08-02 |
| 13F-HR | 2023-05-02 |
| 13F-HR | 2023-02-03 |
| 13F-HR | 2022-11-03 |
| 13F-HR | 2022-08-02 |
| 13F-HR | 2022-05-04 |
| 13F-HR | 2022-02-02 |
View C WorldWide Group Holding A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.